Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Differentiated Thyroid Carcinoma 1

Interventions

Specimen Handling 118 Magnetic Resonance Spectroscopy 115 Cyclophosphamide 98 pembrolizumab 82 Radiotherapy 78 Nivolumab 67 Cisplatin 64 fludarabine 59 Biopsy 55 Carboplatin 53 Standard of Care 45 Radiosurgery 43 Dexamethasone 40 Gemcitabine 39 Radiation 37 Paclitaxel 36 venetoclax 35 Rituximab 35 Cytarabine 35 Bevacizumab 35 Surveys and Questionnaires 34 Doxorubicin 33 fludarabine phosphate 31 Temozolomide 31 Radiotherapy, Intensity-Modulated 30 Capecitabine 30 Practice Guidelines as Topic 29 Blood Specimen Collection 29 Interviews as Topic 28 Fluorouracil 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Iodine-124 × 30 days × Clear all

NCT01704586 2026-05-12

CLERAD-PROBE

University of Wuerzburg

Phase NA Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡